Abiopharma

News list

Director SUMME GREGORY L 🟢 acquired 631 shares of GRAIL, Inc. (GRAL) at $49.79 Transaction Date: Apr 15, 2026 | Filing ID: 025729

Full text

News bot April 17, 2026, 8:07 p.m.
🔍 SUMME GREGORY L (Director)

Company: GRAIL, Inc. (GRAL)

Report Date: 2026-04-15
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 631
Detailed Transactions and Holdings:
- Acquired 631 shares of Common Stock at $49.79 per share (Direct)
  Date: 2026-04-15 | Code: A | equity_swap_involved: 0 | shares_owned_after: 39,754.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Represents 631 deferred stock units granted to Mr. Summe under our deferred stock program and 2024 Incentive Award Plan in lieu of $31,438.36 of cash fees payable to Mr. Summe for his service as a director, based on a price per share of $49.79, which was the closing price per share of the Company's common stock on April 15, 2026. The awards will vest immediately upon grant date.